logo
搜索
菜单

bioavailab的搜索结果

当前1/4页
排序: 今日浏览数
Analytical Techniques for Assaying Nitric Oxide Bioactivity 10.3791/3722-v 11:28 min
Analytical Techniques for Assaying Nitric Oxide Bioactivity
16.17: Intrauterine Drug Delivery Systems 01:21 min
16.17: Intrauterine Drug Delivery Systems
16.11: Oral Drug Delivery Systems: Introduction 01:23 min
16.11: Oral Drug Delivery Systems: Introduction
16.4: Modified-Release Drug Delivery Systems: Bioavailability 01:30 min
16.4: Modified-Release Drug Delivery Systems: Bioavailability
13.11: Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption 01:23 min
13.11: Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
13.9: Pharmacokinetics in Obese Patients: Drug Absorption and Distribution 01:25 min
13.9: Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
12.13: IV Infusion to Oral Dosing: Conversion Methods 01:28 min
12.13: IV Infusion to Oral Dosing: Conversion Methods
12.13: IV Infusion to Oral Dosing: Conversion Methods 01:28 min
12.13: IV Infusion to Oral Dosing: Conversion Methods
12.7: Dosage Interval and Administration Route: Determination Methods 01:19 min
12.7: Dosage Interval and Administration Route: Determination Methods
12.3: Dosage Regimen: Multiple Oral Dosage 01:25 min
12.3: Dosage Regimen: Multiple Oral Dosage
12.2: Dosage Regimens: Partial Pharmacokinetic Parameters 01:01 min
12.2: Dosage Regimens: Partial Pharmacokinetic Parameters
11.5: Bioequivalence of Drugs: Drugs with Multiple Indications 01:09 min
11.5: Bioequivalence of Drugs: Drugs with Multiple Indications
11.4: Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence 01:27 min
11.4: Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
10.7: Drug Product Performance: In Vitro–In Vivo Correlation 01:20 min
10.7: Drug Product Performance: In Vitro–In Vivo Correlation
10.3: In Vitro Drug Dissolution: Compendial Testing Models I 01:13 min
10.3: In Vitro Drug Dissolution: Compendial Testing Models I
10.1: Biopharmaceutical Factors Influencing Drug Product Design: Overview 01:22 min
10.1: Biopharmaceutical Factors Influencing Drug Product Design: Overview
9.15: Bioequivalence studies: Biowaivers 01:13 min
9.15: Bioequivalence studies: Biowaivers
9.13: Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs 01:20 min
9.13: Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
9.11: Bioavailability Enhancement: Drug Stability Enhancement and GI Retention 01:05 min
9.11: Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
9.10: Bioavailability Enhancement: Drug Permeability Enhancement 01:27 min
9.10: Bioavailability Enhancement: Drug Permeability Enhancement
返回顶部